Incidence of major and clinically relevant non-major bleeding in patients prescribed rivaroxaban for stroke prevention in non-valvular atrial fibrillation in secondary care: Results from the Rivaroxaban Observational Safety Evaluation (ROSE) study

• Alison Evans ,

  Roles Conceptualization, Investigation, Project administration, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: alison.evans@dsru.org

  Affiliations Drug Safety Research Unit, Southampton, United Kingdom, University of Portsmouth, Portsmouth, United Kingdom

  http://orcid.org/0000-0003-1878-2429

  ⨯
• Miranda Davies,

  Roles Conceptualization, Methodology, Writing – review & editing

  Affiliations Drug Safety Research Unit, Southampton, United Kingdom, University of Portsmouth, Portsmouth, United Kingdom

  ⨯
• Vicki Osborne,

  Roles Conceptualization, Formal analysis, Methodology, Writing – review & editing

  Affiliations Drug Safety Research Unit, Southampton, United Kingdom, University of Portsmouth, Portsmouth, United Kingdom

  http://orcid.org/0000-0002-3669-6084

  ⨯
• Debabrata Roy,

  Roles Formal analysis, Writing – review & editing

  Affiliations Drug Safety Research Unit, Southampton, United Kingdom, University of Portsmouth, Portsmouth, United Kingdom

  ⨯
• Saad Shakir

  Roles Conceptualization, Methodology, Supervision, Writing – review & editing

  Affiliations Drug Safety Research Unit, Southampton, United Kingdom, University of Portsmouth, Portsmouth, United Kingdom

  ⨯